Bio Medica Laboratories (NSE:BMLL) Preferred Dividends: ₹0.0 Mil (TTM As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BMLL Bio Medica Laboratories Ltd NSE:BMLL
18 GF Score
Price ₹146.80
! 7 Warning Signs
View Full Analysis

What is Bio Medica Laboratories Preferred Dividends?

Bio Medica Laboratories NSE:BMLL +1.21% 18 Preferred Dividends is ₹0.0 Mil as of Mar. 2025. GuruFocus rates NSE:BMLL with a GF Score™ of 18/100. The stock has 7 warning signs investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Bio Medica Laboratories's preferred dividends for the six months ended in Mar. 2025 was ₹0.0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

Bio Medica Laboratories  (NSE:BMLL) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Medica Laboratories Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Bio Medica Laboratories's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Medica Laboratories Preferred Dividends Chart

Bio Medica Laboratories Annual Data
Trend Mar23 Mar24 Mar25
Preferred Dividends
0.00 0.00 0.00

Bio Medica Laboratories Semi-Annual Data
Mar23 Mar24 Mar25
Preferred Dividends 0.00 0.00 0.00
NSE:BMLL
18GF Score
Bio Medica Laboratories Ltd NSE:BMLL
Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Medica Laboratories Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →
What does a Preferred Dividends of ₹0.0 Mil mean?
Bio Medica Laboratories (NSE:BMLL) has a Preferred Dividends of ₹0.0 Mil as of Mar. 2025. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Bio Medica Laboratories and its competitors.
Is Bio Medica Laboratories' Preferred Dividends too high?
Bio Medica Laboratories' current Preferred Dividends is ₹0.0 Mil. Overall, Bio Medica Laboratories has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' Preferred Dividends compare to ISRG and BDX?
Bio Medica Laboratories' Preferred Dividends of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Dividends for a Medical Devices & Instruments company?
A good Preferred Dividends depends on the Medical Devices & Instruments industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Dividends mean?
A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Bio Medica Laboratories and its competitors. Bio Medica Laboratories's current Preferred Dividends is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current Preferred Dividends of ₹0.0 Mil. The current Preferred Dividends is ₹0.0 Mil. Bio Medica Laboratories' overall GF Score™ is 18/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Dividends calculated?
Preferred Dividends is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current Preferred Dividends is ₹0.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio Medica Laboratories Business Description

Address Sanwer Road, Plot No. 11B-11C, Sector-E, Industrial Area, Industrial Estate - Indore, Indore, MP, IND, 452015
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
18GF Score

Get the complete analysis for NSE:BMLL

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹146.80
Price